Imaging with ^sup 124^I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT?

Purpose The aim of this study was to compare integrated PET/CT and PET/MRI for their usefulness in detecting and categorizing cervical iodine-positive lesions in patients with differentiated thyroid cancer using ^sup 124^I as tracer. Methods The study group comprised 65 patients at high risk of iodine-positive metastasis who underwent PET/CT (low-dose CT scan, PET acquisition time 2 min; PET/CT^sub 2^) followed by PET/MRI of the neck 24 h after ^sup 124^I administration. PET images from both modalities were analysed for the numbers of tracer-positive lesions. Two different acquisition times were used for the comparisons, one matching the PET/CT^sub 2^ acquisition time (2 min, PET/MRI^sub 2^) and the other covering the whole MRI scan time (30 min, PET/MRI^sub 30^). Iodine-positive lesions were categorized as metastasis, thyroid remnant or inconclusive according to their location on the PET/CT images. Morphological information provided by MRI was considered for evaluation of lesions on PET/MRI and for volume information. Results PET/MRI^sub 2^ detected significantly more iodine-positive metastases and thyroid remnants than PET/CT^sub 2^ (72 vs. 60, p=0.002, and 100 vs. 80, p=0.001, respectively), but the numbers of patients with at least one tumour lesion identified were not significantly different (21/65 vs. 17/65 patients). PET/MRI^sub 30^ tended to detect more PET-positive metastases than PET/MRI^sub 2^ (88 vs. 72), but the difference was not significant (p=0.07). Of 21 lesions classified as inconclusive on PET/CT, 5 were assigned to metastasis or thyroid remnant when evaluated by PET/MRI. Volume information was available in 34 % of iodine-positive metastases and 2 % of thyroid remnants on PET/MRI. Conclusions PET/MRI of the neck was found to be superior to PET/CT in detecting iodine-positive lesions. This was attributed to the higher sensitivity of the PET component, Although helpful in some cases, we found no substantial advantage of PET/MRI over PET/CT in categorizing iodine-positive lesions as either metastasis or thyroid remnant. Volume information provided by MRI for some iodine-positive lesions might be useful in dosimetry.